Max Chat
GlaxoSmithKline
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
7/10
|
21.56 | 52.65 | -59.04% | 12.8 | +68.48% |
| P/S |
|
1.77 | 4.03 | -56.12% |
|
|
| P/BV |
|
4.24 | 10.87 | -60.96% |
|
|
| P/FCF |
|
19.71 | 39.64 | -50.26% |
|
|
| Ev/Ebitda |
|
10.32 | 16.12 | -35.96% |
|
|
| Ev/S |
|
2.19 | 4.35 | -49.6% |
|
|
| Ev/FCF |
|
19.26 | 52.31 | -63.17% |
|
|
| E/P |
|
0.0366 | 0.2095 | -82.53% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
7/10
|
21.25 | 19.07 | 11.44% | 25.54 | -16.8% |
| ROE |
|
19.06 | -83.32 | -122.88% |
|
|
| ROA |
|
4.35 | 6.38 | -31.85% |
|
|
| ROIC |
|
12.84 | 15.06 | -14.75% |
|
|
| ROS |
|
8.21 | 9.34 | -12.05% |
|
|
| ROCE |
|
31.46 | 67.03 | -53.07% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
5/10
|
2.55 | 1.02 | 150.15% | 2.45 | +3.91% |
| Nеt Debt/Ebitda |
|
1.99 | 1.4 | 42.46% |
|
|
| Debt/Ratio |
|
0.2857 | 0.2741 | 4.22% |
|
|
| Debt/Equity |
|
3.54 | 13.6 | -73.94% |
|
|
| Debt/Net Income |
|
6.6 | 6.8 | -2.98% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
9.98/10
|
3.99 | 1.28 | 211.06% | 4.66 | -14.42% |
| Number of years of dividend growth |
|
1 | 6.75 | -85.18% | ||
| DSI |
|
0.7857 | 0.7413 | 5.99% |
|
|
| Average dividend growth |
|
-2.24 | -4.1 | -45.54% |
|
|
| Average percentage for 5 years |
|
4.66 | 1.34 | 249.24% |
|
|
| Average percentage for payments |
|
97.89 | 44.08 | 122.05% |
|
|
| Difference from average difference in sector |
|
2.71 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-7.99 | 12.47 | -164.07% | ||
| Growth impulse Ebitda in 5 years |
|
-21.4 | -86.3 | -75.2% | ||
| Growth impulse Net Income in 5 years |
|
-55.21 | -75.86 | -27.22% | ||
| Growth impulse FCF in 5 years |
|
-42.41 | -79.28 | -46.51% | ||
| Growth impulse EPS in 5 years |
|
-67.19 | 4.34 | -1648.16% |
IP Score
4.91/10
